Rezultati pretraživanja
  1. 1. velj

    Shine like a diamond, miss polychaete! We found this in sand from the ocean. Pure luck. Such an amazing creature❤❤

  2. prije 3 minute

    GS Feb 24-27 west was Coast tour , , GRTS , VRTX, VIR BHC ,

  3. prije 14 minuta

    held that $2.70 area confirming support from Fri. News is needed to move this I guess. Watching specific price points for entry.

  4. Working onsite today in Mt View! Workforce planning & 2020 hiring timelines! & & & & tbassoni @ Mountain View, California

  5. prije 45 minuta

    Bioconjugate R&D Scientist – Broadpharm – San Diego, CA via SDBN Jobs: Strong organizational skills and attention to detail. Support QC testing and release of reagent products as assigned. In ...

  6. Thanks for the fruitful discussion, a good starting point. Looking forward to work together and make this happen!

  7. prije 1 sat

    soon as I see $2.85 on the bid of decent size I'm joining. It's close to making some kind of move. Hopefully in line w/ the bulls.

  8. prije 1 sat

    Detecting diseases with magnetically levitated plasma proteins via

  9. SFBN Feed: Redwood City biotech boosts IPO targets, hopes to raise up to $184M: Revolution Medicines Inc. appears likely to be the second Bay Area IPO of the year, setting price targets on Monday to raise up ...

  10. SFBN Feed: TESS Research Foundation Selected as Part of Chan Zuckerberg Initiative Rare As One Project: MENLO PARK, Calif.--(BUSINESS WIRE)--Today, TESS Research Foundation (TESS) was announced as an awardee ...

  11. prije 2 sata

    super strong today 🤙🏼 Does the buyout finally happen?!?

  12. prije 3 sata

    With political debates coming up, a focus will be the high price of orphan drugs. How dare pharmas exploit a $2M+ price to someone without parents?

  13. fights back

  14. 2. velj

    Just a guess: has some strong action tomorrow ✅✅

  15. 2. velj

    What its like to trade penny stocks.

  16. 28. sij

    “There is still a stigma in the industry around failures even though we operate in a high-risk, cutting edge environment where roughly nine out of every ten drugs that enter clinical trials will fail."

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.